Latest News

CenterPoint Energy (CNP) is back in focus after fourth quarter 2025 earnings matched expectations, the company reaffirmed its 2026 non GAAP earnings guidance, detailed new grid projects, and announced a 9% dividend increase. See our latest analysis for CenterPoint Energy. Recent earnings, grid investment plans and the 9% dividend increase have come alongside firm share price momentum, with a 30 day share price return of 8.89% and a 1 year total shareholder return of 29.59% that extends to...

If you are wondering whether Corvus Pharmaceuticals' recent share price puts it at a bargain or a stretched level, you are not alone. This article is here to unpack what that current price might mean for value focused investors. The stock has been volatile, with a 7 day return of an 11.7% decline and a 30 day return of a 22.8% decline, set against a year to date return of 115.8% and a 1 year return of 271.6%, plus an increase of more than 7x over 3 years and 381.6% over 5 years. Recent...

Zealand Pharma (CPSE:ZEAL) is under close watch after Phase 2 topline data for obesity drug candidate petrelintide triggered a sharp share price drop, despite meeting the trial’s primary weight loss and safety goals. See our latest analysis for Zealand Pharma. The sharp 1 day share price return of 36.4% and 7 day share price return of 36.1% have reversed much of Zealand Pharma’s earlier gains. However, the 3 year total shareholder return of 4.9% and 5 year total shareholder return of 23.7%...

Austevoll Seafood (OB:AUSS) just released its fourth quarter and full year 2025 results, reporting higher sales but sharply weaker net income. This combination points to margin pressure and raises fresh questions for shareholders. See our latest analysis for Austevoll Seafood. The weak profit result comes after a period of solid share price momentum, with Austevoll Seafood’s share price returning 6.24% over 7 days, 10.78% over 30 days and 15.98% over 90 days. The 1 year total shareholder...

Revolve Group, Inc. recently launched Revolve Los Angeles, its first namesake fashion house inspired by its hometown, offering couture-influenced womenswear priced between US$200 and US$3,500 in sizes XXS to XL, available exclusively on Revolve and FWRD. This move expands Revolve’s in-house brand portfolio into higher-end, craftsmanship-focused apparel, signalling a push to deepen brand identity and capture more luxury-oriented spending. We’ll now explore how this higher-end Revolve Los...

Shimano (TSE:7309) is back in the spotlight after two shareholder focused moves: a proposed higher year end dividend for fiscal 2025 and a rejected call for a large, rapid share buyback. See our latest analysis for Shimano. These dividend and buyback debates come after a tougher period for shareholders, with a 1 year total shareholder return of 22.5% decline and a 5 year total shareholder return of 28.9% decline, while the 1 month share price return of 11.3% decline suggests recent momentum...

In recent days, Essex Property Trust’s fourth-quarter 2025 results came in below expectations while the company’s board approved a 0.8% annual dividend increase, marking its 32nd consecutive year of dividend growth. At the same time, a mix of cautious analyst commentary and industry concerns about below pre-COVID multifamily occupancy levels has sharpened investor focus on how Essex balances income stability with near-term operational challenges. Next, we’ll examine how Essex’s earnings...

Taseko Mines Limited has reported that its Florence Copper operation in Arizona has produced its first copper cathodes from the newly completed commercial facility, marking the first new copper output from a greenfield U.S. site since 2008 and the first global greenfield use of in-situ copper recovery (ISCR) technology. The company expects Florence Copper to reach an annual nameplate capacity of 85 million pounds of LME Grade A copper and at least 1.50 billion pounds over 22 years,...

Why Celcuity (CELC) is Drawing Fresh Attention Celcuity (CELC) has come into focus after recent share price moves and its role as a clinical-stage biotechnology company working on targeted therapies for solid tumors, including advanced breast and prostate cancers. See our latest analysis for Celcuity. The current US$115.0 share price comes after a 6.2% 7 day share price return and an 11.9% 90 day share price return. The 1 year total shareholder return is very large, hinting that recent moves...

Leadership change and why it matters for Wacoal Holdings (TSE:3591) Wacoal Holdings (TSE:3591) is back in focus after its board confirmed that Akira Miyagi will step down as CFO and director on April 1, 2026, following a February 24 meeting. See our latest analysis for Wacoal Holdings. The leadership change headlines arrive after a softer patch in the share price, with a 7 day share price return of 6.01% decline and a 1 year total shareholder return of 13.55% decline. However, the 3 and 5...

LEG Immobilien (XTRA:LEG) has drawn fresh attention after reporting full year 2025 earnings and confirming an annual dividend of €2.92 per share, with payment scheduled for June 1, 2026. See our latest analysis for LEG Immobilien. LEG Immobilien’s share price has held at €65.35 after the earnings and dividend announcements, with a 30 day share price return of 5.74% and a 90 day gain of 6.09%. The 3 year total shareholder return of 20.73% contrasts with a 5 year total shareholder return...

Why Denali’s recent earnings and shelf registration matter for shareholders Denali Therapeutics (DNLI) has drawn fresh attention after reporting a wider fourth quarter and full year 2025 loss alongside a new US$200.7 million shelf registration for common stock, raising questions about dilution and funding plans. For the fourth quarter, Denali reported a net loss of US$128.55 million, with basic and diluted loss per share from continuing operations of US$0.73, compared with US$0.67 a year...

In early March 2026, Incyte received European Commission approval for Zynyz (retifanlimab) plus carboplatin and paclitaxel as first-line treatment for adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal, based on Phase 3 POD1UM-303 data showing improved progression-free survival versus chemotherapy alone. This second European indication for Zynyz strengthens Incyte’s immuno-oncology portfolio in a rare cancer setting, underpinned by...

Why Bob's Discount Furniture Is On Investors' Radar Bob's Discount Furniture (BOBS) has drawn attention after a sharp 5.5% decline in the latest session, extending a roughly 18% slide over the past week. At the same time, the share price shows a small gain over the past month and a modest positive return so far this year, giving investors mixed signals on short term sentiment. See our latest analysis for Bob's Discount Furniture. The recent 1 day share price return of a 5.46% decline and 7...

Earnings rebound and dividend announcement put Ramsay Health Care in focus Ramsay Health Care (ASX:RHC) has drawn fresh attention after reporting half year earnings to 31 December 2025 that moved from a loss to a profit, alongside a declared interim dividend. See our latest analysis for Ramsay Health Care. The earnings rebound and interim dividend have landed against a mixed price backdrop, with a 16.39% 1 month share price return and 17.27% 3 month share price return, but a 34.91% 3 year...

Avnet (AVT) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past week and month while remaining higher over the past 3 months and year. See our latest analysis for Avnet. That pullback, with a 1 month share price return of 9.86% decline and a 1 week share price return of 7.59% decline, comes after a stronger run that leaves Avnet with a 1 year total shareholder return of 24.26% and 3 year total shareholder return of 53.29%. This...

Huishang Bank (SEHK:3698) has drawn fresh attention after issuing a positive profit alert and preliminary FY2025 figures. The bank highlighted higher total assets, improved profitability, and better reported asset quality metrics. See our latest analysis for Huishang Bank. The positive profit alert has arrived alongside renewed interest in the stock, with an 8.53% 1 day share price return, a 22.96% 90 day share price return, and a 65.90% 1 year total shareholder return. This suggests that...

Earnings milestone and buyback completion put REX American Resources in focus REX American Resources (REX) extended its streak to 21 consecutive profitable quarters with stronger-than-expected earnings, while a completed multi-year buyback that retired about 3.6 million shares supported earnings per share. See our latest analysis for REX American Resources. At a share price of $37.38, REX American Resources has seen steady positive momentum, with a 90 day share price return of 14.7% and a 1...

Earnings and corporate actions draw fresh attention to DiamondRock Hospitality DiamondRock Hospitality (DRH) is back on investor radars after its latest quarterly update, which combined a move from quarterly loss to profit, a higher dividend, a completed buyback, and upcoming board changes. See our latest analysis for DiamondRock Hospitality. At a share price of $9.60, DiamondRock Hospitality has seen a 9.34% 90 day share price return and a 20.40% 1 year total shareholder return. This...

Recent share performance and business snapshot Vaisala Oyj (HLSE:VAIAS) has recently seen mixed short term returns, with a 1 day decline of 1.66% and a small drop over the past week, set against positive performance over the past month and past 3 months. For context, the company reports annual revenue of €596.9m and net income of €59.8m, alongside annual revenue growth of 5.25% and net income growth of 12.60%, highlighting its role in weather, environmental, and industrial measurement...

Global Chinese Business Club (SEHK:1757) has drawn attention after its previous auditor resigned over a fee disagreement, and the company swiftly appointed Wilson & Partners CPA, alongside a planned reduction in Hong Kong board lot size. See our latest analysis for Global Chinese Business Club. The recent auditor change and plan to cut the Hong Kong board lot size come alongside very strong share price momentum, with a 7 day share price return of 69.5% and a 30 day share price return of...

Why DraftKings' Super App Plans Matter for DKNG Holders DraftKings (DKNG) has put its planned Super App front and center, aiming to fold Sportsbook, Casino, Lottery and Prediction products into one platform, deepen its ESPN-linked features, and simplify the user experience. See our latest analysis for DraftKings. Despite the Super App announcement, account linking with ESPN, new market entries like Arkansas and Puerto Rico, and mixed legal headlines, DraftKings’ recent momentum has been weak,...

In early March 2026, regional bank stocks including Citizens Financial Group came under pressure after Western Alliance Bancorporation disclosed a US$126.40 million loan write-off tied to a default in the opaque private credit market. At the same time, Citizens continued to push its "Reimagine the Bank" digital transformation and agreed to acquire most assets of Matrix Capital Markets Group, broadening its advisory capabilities in the downstream energy and convenience retail sector. Next,...

Full year 2025 earnings reset the conversation Civitas Resources (CIVI) recently reported full year 2025 results, with revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, putting the stock back under closer investor review. See our latest analysis for Civitas Resources. At a share price of US$27.38, Civitas Resources has seen a 5.0% decline in its 90 day share price return and a 43.4% drop in its 1 year total shareholder return. This suggests momentum...